Does Computer Simulation Help Facilitate Personalized Precision Medicine for the Use of Warfarin?
Does Computer Simulation Help Facilitate Personalized Precision Medicine for the Use of Warfarin?
复制标题
计算机模拟是否有助于促进华法林使用的个性化精准医疗?
DOI:
10.1161/circgenetics.117.001969
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Goto S and Goto S
中科院分区:
文献类型:
--
作者:
Goto S;Merrill P;Wallentin L;Wojdyla DM;Hanna M;Avezum A;Easton JD;Harjola VP; Huber K;Lewis BS9;Yabushita H and Goto S;Goto S and Goto S
2 Goto and Goto Does Simulation Facilitate Precision Medicine? randomized clinical trial results–based medicine (evidencebased medicine) and the future expected pure precision medicine based on the constructive logic. The method Ravvaz et al1 has proposed creates a simulation model based on pharmacodynamics and pharmacokinetics from an existing cohort composed of real patients. This model allows calculation of outcomes from parameters, such as age, sex, race, genetic information, etc., and can produce avatars that mimic the actual patients. Thus, the model allows us to prepare as many participants in virtual clinical trials as we need and allows us to perform enormous numbers of virtual clinical trials testing multiple clinical hypothesis. However, the model proposed by Ravvaz et al1 currently includes only simple parameters. There are many other factor potentially influencing PT-INR control, such as rarely used drug intake, bacterial infection, etc. Furthermore, the calculation of outcomes from warfarin intakes is greatly simplified in this model. Both PT-INR and clinical outcome should be influenced by complicated cell-based coagulation, 10 which was not implemented in this model. The method Ravvaz et al1 reported in this article is interesting but just the simple beginning. Future expansion of research in this area is expected.